EDITORIAL
Published on 22 Feb 2021
Editorial: Antipsychotics of New Generation: Where Are We now?
doi 10.3389/fphar.2021.646286
- 1,663 views
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Antipsychotics of a New Generation: Where Are We Now?
Antipsychotics of a New Generation: Where Are We Now?
7,904
Total downloads
24k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 16 Oct 2020
Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia
doi 10.3389/fphar.2020.486811
- 5,694 views
- 37 citations
STUDY PROTOCOL
Published on 30 Apr 2020
Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
doi 10.3389/fphar.2020.00591
- 3,789 views
- 12 citations
REVIEW
Published on 29 Jan 2020
Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
doi 10.3389/fphar.2019.01638
- 3,345 views
- 16 citations
ORIGINAL RESEARCH
Published on 26 Nov 2019
Association Study of the Complement Component C4 Gene in Tardive Dyskinesia
doi 10.3389/fphar.2019.01339
- 2,358 views
- 15 citations
BRIEF RESEARCH REPORT
Published on 03 May 2019
Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
doi 10.3389/fphar.2019.00470
- 2,746 views
- 16 citations
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Impact
- 24kTopic views
- 16kArticle views
- 7,904Article downloads